SHL Medical is pleased to announce the appointment of Gwenaël Rouy-Poirier as Chief Financial Officer (CFO) of SHL and a member of the Executive Management Team as of May 2, 2023.
Menu
SHL Medical achieves ISO 14001 Environmental Management Systems certification and ISO 45001 Occupational Health and Safety Management Systems certification.
SHL Medical is pleased to announce our participation in CPHI Japan 2023 for the first time.
SHL Medical is excited to announce its participation in the SCbio 2023 Annual Conference. The event will provide a platform for industry leaders, academic experts, and investors to network, collaborate and learn about the latest trends in biotechnology, healthcare, and life sciences.
In the February issue of ONdrug Delivery magazine, Michael McGowan, Senior Director of Market Intelligence at SHL Medical, examines the emerging interest within the pharmaceutical industry for autoinjectors that are capable of delivering higher injection volumes into the subcutaneous space.
To support the victims of the earthquake in Türkiye and Syria, SHL Medical has donated a total of US$100,000 to the UNHCR and Doctors Without Borders/Médecins Sans Frontières.
SHL Medical is pleased to announce the appointment of Satbir Bains as Chief Human Resources Officer (CHRO) of SHL and a member of the Executive Management Team as of February 2023.
SHL Medical is opening 2023 with our participation in Pharmapack Europe.
SHL Medical is excited to announce our first-time participation in the NSTC Science Train Program, 2022.
